CRISPR Therapeutics Announces Oral Presentation of New Data on CTX001, a CRISPR Gene-Edited Therapy for β … – GlobeNewswire (press release)
Seeking Alpha |
CRISPR Therapeutics Announces Oral Presentation of New Data on CTX001, a CRISPR Gene-Edited Therapy for β …
GlobeNewswire (press release) Data presented at ASH demonstrate that CRISPR Therapeutics' proprietary CRISPR gene-editing approach results in high editing efficiency, with >90% of the hematopoietic stem cells edited at the target site. A vast majority of these cells are edited on … CRISPR Therapeutics: Analysis Of And Update On The B-Thalassemia Franchise CRISPR Therapeutics Announces Oral Presentation of New Data on CTX001, a CRISPR Gene-Edited Therapy for ß … Crispr Therapeutics AG (NASDAQ:CRSP) Just Reported Increased Shorts |
